EryonStudio, healthcare motion design studio
Our films, the method, the communication kit and the process, from idea to final version.
EryonStudio
Uses
Patient education video
Patient education video: explaining a disease, every line referenced
A patient education video explains a disease in plain words: what happens in the body, the tests, the follow-up and who to talk to. EryonStudio, Eryon's video studio in Lille, France, makes it for care teams, patient organisations, pharmaceutical companies and manufacturers, with a first version within a few days. Every line of the script is tied to its source and to the exact passage that supports it.
The video at a glance
- Audience Patients and familiesGiven by the care team, the patient organisation or the doctor
- Suggested length About 3 minutesOur awareness films run from 2 min 59 to 4 min 17
- First version Within a few daysUp to 60 seconds, in motion design, in the language you choose
- Evidence Every line referencedIts reference, its page and the exact passage that supports it
- Quote After the first versionYou judge it on screen before ordering the rest
A tool for your care team, never a therapeutic patient education programme
What a patient education video explains
It answers a patient's questions in order: what is happening in their body, what will happen next and who to turn to.
-
How the disease works, in a medical explainer video
What goes wrong in the organ, the vessel or the cell, shown in motion rather than described. Motion design and medical animation make visible what a leaflet explains poorly, without going into more detail than the patient wants.
-
An educational film for patients, from diagnosis to follow-up
The signs, the diagnostic tests, the follow-up and the professionals the patient will meet: the film prepares the patient for what will happen. A test or a procedure can be shown in full, as it takes place.
-
A therapeutic patient education video for sessions
A resource the team shows in individual or group sessions, or gives to patients so they can review at home what was covered. The film follows the programme's objectives: it supports what the clinicians say without replacing it.
-
A plain-language medical video, without approximation
Simplifying without distorting: every line of the script is tied to a reference, with its page and the exact passage that supports it. If the source does not say exactly what the line says, we rewrite the line, never the source.
-
A health education video that refers to the doctor
No individual advice. When the film mentions treatments, it presents the families on an equal footing, with no product or brand name, and every care decision refers to the doctor or the team caring for the patient.
-
For patients and their families
The film also speaks to those close to the patient: it gives the same reference points to the patient and to those who support them. With subtitles, it can be watched without sound, in the waiting room or at home, and can be adapted into several languages.
The hip explained to patients
Our film on hip osteoarthritis follows the questions of a patient and their family: the signs, the diagnosis, the treatments without surgery, then the point at which a replacement is discussed. The risks are stated in figures, and every decision refers to the surgeon and the doctor caring for the patient.
- For
- An Eryon film, health information
- Audience
- Patients and relatives
- Running time
- 4 min 17
- Justification
- 35 lines, 36 references, 199 exact passages
Five situations, from hospital to pharma
The place and the moment change, not the rule: the video supports what clinicians say.
A therapeutic patient education team wants a shared film to open its group sessions, which patients can watch again at home.
A patient organisation wants to explain the disease to people who have just been diagnosed, and to their families.
A hospital department wants a film to send before a first appointment or to show in the waiting room.
A pharmaceutical company wants to fund information about the disease, written and reviewed with clinicians, with no product or brand.
A medical device manufacturer wants to explain the disease its device helps to monitor, without showing its product.
Plain words, verifiable sources
Here, scoping also sets what the film leaves to the care team: individual advice and the discussion of treatments. Your clinicians review the script, line by line, before the final version.
- 01
Scoping, in 30 minutes
Objective, audience, where the video will be shown, available references and regulatory points to watch.
- 02
The referenced script
Every line is tied to a reference, with its page and the exact passage that supports it.
- 03
The visuals
Motion design and medical animation, with AI assisting part of the production. Diagrams remain illustrations.
- 04
Checks and delivery
An automated check finds every passage, word for word, on the page cited; two independent AI-assisted audits then re-check a sample in the documents; your review committee, or your MLR review in a pharmaceutical company, approves the final version.
What you receive
With subtitles, the film can be watched without sound, in the waiting room or in a session; with the justification file, your team knows where every line comes from when a patient asks a question.
The film and its broadcast files
Landscape for your website, YouTube and the training room; portrait, square or 4:5 for social media.
Subtitles and transcript
SRT file and full text: accessibility, viewing without sound and search visibility for the page that hosts the film.
The script and the justification file
Every line, its reference, its page and the exact passage, ready for your internal review.
The bibliographic references
The full list, in order of appearance, with links to the public sources.
The versions you need
Short excerpts, stills, a poster or slides, depending on your channels. Quoted with the final version.
Languages
The languages you choose: every translated line keeps its source and exact passage, and the rules of the country where the video is shown are checked at scoping.
Therapeutic patient education in France: what the law allows
In France, therapeutic patient education is governed by Articles L.1161-1 to L.1161-6 of the French Public Health Code. Its programmes follow a national specification and, since 1 January 2021, are declared to the ARS, the regional health authority (Article L.1161-2). A company that markets a medicine or a medical device, like a company providing health-related services, can neither design nor run a programme; it can take part, in particular by funding it, if healthcare professionals and approved patient and user organisations design and run it (Article L.1161-4). A video is a tool serving the care team, not a programme: we write it with the team, and we neither design nor run any programme.
Frequently asked questions
What is therapeutic patient education?
In France, it is an approach that forms part of the care pathway and aims to make patients more autonomous, by helping them follow their prescribed treatments and improving their quality of life (Article L.1161-1 of the French Public Health Code). It takes place in programmes run by a team of trained clinicians and declared to the ARS, the regional health authority. A video is not a programme: it is a tool the team uses in its sessions.
What are the 4 steps of therapeutic patient education?
According to the Haute Autorité de santé (HAS), the French National Authority for Health, the approach is planned in four steps: an educational diagnosis, now called the shared educational assessment; a personalised programme with learning priorities; individual, group or alternating sessions; an assessment of the skills acquired and of how the programme went. Video fits mainly into the third step: the HAS lists video among the tools for sessions, alongside posters and leaflets.
How do you explain a disease to a patient on video?
By following the order of their questions: what is happening in their body, what they may feel, how the diagnosis is made, what will happen next and who to talk to. One idea per line, everyday words, every technical term explained the first time, and the mechanism shown in motion rather than described. Every line rests on a source, and the film refers to the doctor whenever a care decision comes up.
Can a pharmaceutical company fund a therapeutic patient education video?
Yes, under conditions. In France, a company that markets a medicine or a medical device can take part in a programme, in particular by funding it, but can neither design nor run it: that role belongs to healthcare professionals and approved patient and user organisations (Article L.1161-4 of the French Public Health Code), and the same rule applies to a service company like ours. The programme must have no promotional aim and must state its sources of funding (ministerial order of 30 December 2020). So we write the video with no product or brand.
Does a therapeutic patient education video have to be declared to the ARS?
No, not as such: it is the programme that is declared to the ARS, the French regional health authority (Article L.1161-2 of the French Public Health Code), and its specification provides for describing its teaching tools where relevant. Programmes teaching the techniques needed to use a medicine follow a different rule: they are authorised by the ANSM, with their documents and materials (Article L.1161-5). A video intended for such a programme is therefore part of the authorisation application.